1. A novel structural status assessment of oa is strongly associated with all patient important outcomes - an mri study of 9, 433 knees from the osteoarthritis initiative. Issue 1 (April 2020) Authors: Bowes, M.A.; Kacena, K.A.; Alabas, O.; Brett, A.D.; Dube, B.; Bodick, N.; Conaghan, P.G. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials. (April 2017) Authors: Conaghan, P.; Strand, V.; Hunter, D.; Kraus, V.B.; Berenbaum, F.; Katz, N.P.; Lufkin, J.; Johnson, J.R.; Kelley, S.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dose-dependent chondroprotective effects of triamcinolone acetonide on inflamed and injured cartilage using an in vitro model. (April 2019) Authors: Frank, E.; Hung, H.-H.; Krishnan, Y.; Senter, B.; Bodick, N.; Grodzinsky, A. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prolonged joint residency of triamcinolone acetonide after an intra-articular injection of FX006, a sustained release formulation for the treatment of osteoarthritis. (April 2015) Authors: Bodick, N.; Lufkin, J.; Willwerth, C.; Hauben, J.; Kumar, A.; Boen, P.; Bolognese, J.; Schoonmaker, C.; Clayman, M. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study. (April 2016) Authors: Conaghan, P.G.; Cohen, S.; Jordan, J.; Berenbaum, F.; Lufkin, J.; Wilwerth, C.; Clayman, M.; Doyle, M.K.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis. Issue 1 (January 2015) Authors: Kumar, A.; Bendele, A.M.; Blanks, R.C.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 23:Issue 1(2015) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA). Issue 1 (January 2018) Authors: Kraus, V.B.; Conaghan, P.G.; Aazami, H.A.; Mehra, P.; Kivitz, A.J.; Lufkin, J.; Hauben, J.; Johnson, J.R.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 26:Issue 1(2018) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis. (April 2017) Authors: Byers-Kraus, V.; Aazami, H.A.; Mehra, P.; Kivitz, A.J.; Lufkin, J.; Hauben, J.; Johnson, J.R.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Systemic and local effects following intra-articular injection of FX006, an extended release, PLGA microsphere formulation of triamcinolone acetonide: results from two nonclinical toxicity studies in dogs. (April 2017) Authors: Williamson, T.L.; Walz, A.; Garlick, D.; Lightfoot-Dunn, R.; Schafer, K.; Kelley, S.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The rat homolog to FX201, a gene therapy in development for the treatment of osteoarthritis, demonstrates dose-dependent decreases in the severity of cartilage and bone lesions following anterior cruciate ligament transection. Issue 1 (April 2020) Authors: Senter, R.; Boyce, R.; Chabicovsky, M.; Martin, E. Walsh; Langevin-Carpentier, G.; Bodick, N. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗